JX5 inhibits the binding of IGF2BP2 to the oncogene NOTCH1 in T-ALL, thereby directly suppressing the proliferation of T-ALL in an m6A-dependent manner. Here, IGF2BP2 is linked to acute lymphoblastic leukemia.